1. Home
  2. EOT vs NKTR Comparison

EOT vs NKTR Comparison

Compare EOT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOT
  • NKTR
  • Stock Information
  • Founded
  • EOT 2009
  • NKTR 1990
  • Country
  • EOT United States
  • NKTR United States
  • Employees
  • EOT N/A
  • NKTR N/A
  • Industry
  • EOT Investment Bankers/Brokers/Service
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EOT Finance
  • NKTR Health Care
  • Exchange
  • EOT Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • EOT 272.2M
  • NKTR 247.9M
  • IPO Year
  • EOT N/A
  • NKTR 1994
  • Fundamental
  • Price
  • EOT $16.59
  • NKTR $0.93
  • Analyst Decision
  • EOT
  • NKTR Buy
  • Analyst Count
  • EOT 0
  • NKTR 3
  • Target Price
  • EOT N/A
  • NKTR $4.00
  • AVG Volume (30 Days)
  • EOT 38.7K
  • NKTR 2.3M
  • Earning Date
  • EOT 01-01-0001
  • NKTR 11-07-2024
  • Dividend Yield
  • EOT 4.51%
  • NKTR N/A
  • EPS Growth
  • EOT N/A
  • NKTR N/A
  • EPS
  • EOT N/A
  • NKTR N/A
  • Revenue
  • EOT N/A
  • NKTR $93,137,000.00
  • Revenue This Year
  • EOT N/A
  • NKTR $12.85
  • Revenue Next Year
  • EOT N/A
  • NKTR N/A
  • P/E Ratio
  • EOT N/A
  • NKTR N/A
  • Revenue Growth
  • EOT N/A
  • NKTR 5.53
  • 52 Week Low
  • EOT $14.63
  • NKTR $0.47
  • 52 Week High
  • EOT $18.30
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • EOT 24.11
  • NKTR 33.04
  • Support Level
  • EOT $16.56
  • NKTR $0.89
  • Resistance Level
  • EOT $17.58
  • NKTR $1.04
  • Average True Range (ATR)
  • EOT 0.18
  • NKTR 0.07
  • MACD
  • EOT -0.09
  • NKTR -0.00
  • Stochastic Oscillator
  • EOT 2.69
  • NKTR 14.81

About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. It invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: